Siloam Hospitals Kelapa Dua, Tangerang, Indonesia.
Faculty of Medicine, Pelita Harapan University, Tangerang, Indonesia.
J Thromb Thrombolysis. 2021 Aug;52(2):635-639. doi: 10.1007/s11239-020-02338-7. Epub 2020 Nov 17.
We have read with great interest the articles regarding cutaneous manifestations in Coronavirus Disease 2019 (COVID-19) infection. Studies showed 20.4% of COVID-19 patients developed cutaneous manifestations. COVID-19 causes vascular endothelial injury, vasculitis and prothrombotic state which might be the underlying cause of hemorrhagic cutaneous manifestations, disseminated intravascular coagulation (DIC), and multiple organ failures. To date, hemorrhagic cutaneous manifestations reported are chilblain-like lesion, purpura to ecchymosis, livedo reticularis, and dry gangrene. We present a case of ecchymosis in COVID-19-positive ICU hospitalized patient.
我们饶有兴趣地阅读了关于 2019 年冠状病毒病（COVID-19）感染皮肤表现的文章。研究表明，20.4%的 COVID-19 患者出现皮肤表现。COVID-19 导致血管内皮损伤、血管炎和血栓前状态，这可能是出血性皮肤表现、弥散性血管内凝血（DIC）和多器官衰竭的潜在原因。迄今为止，报告的出血性皮肤表现有冻疮样病变、瘀斑至瘀点、网状青斑和干性坏疽。我们报告了 1 例 COVID-19 阳性 ICU 住院患者的瘀斑病例。
